Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
March 16, 2017
US Bioservices is now dispensing Novartis’ KISQALI
The U.S Food and Drug Administration recently approved Novartis’ KISQALI (ribociclib) for the treatment of postmenopausal women with HR+/HER2- advanced or metastatic breast cancer.